Thermo Fisher Scientific | TMO - Sales Revenues

Stock Price
470.22
Daily Change
2.18 0.47%
Monthly
-2.05%
Yearly
9.99%
Q2 Forecast
459.66

Thermo Fisher Scientific reported $11.01B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Abbott USD 11.16B 300M Mar/2026
Agilent USD 1.8B 63M Dec/2025
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Bio Techne USD 295.9M 9.34M Dec/2025
Bio-Rad Laboratories USD 693.2M 40.2M Dec/2025
Boston Scientific USD 5.2B 90M Mar/2026
Bruker USD 977.2M 116.7M Dec/2025
Charles River Laboratories USD 994.2M 5.8M Dec/2025
Danaher USD 5.95B 890M Mar/2026
Dentsply International USD 961M 57M Dec/2025
Edwards Lifesciences USD 1.65B 80M Mar/2026
General Electric Aerospace USD 11.6B 270M Mar/2026
Henry Schein USD 3.4B 60M Dec/2025
Illumina USD 1.16B 80M Dec/2025
Intuitive Surgical USD 2.77B 100M Mar/2026
IQVIA Holdings USD 4.36B 260M Dec/2025
Laboratory Of America USD 3.52B 40M Dec/2025
Medtronic USD 9B 39M Jan/2026
Mettler Toledo International USD 1.13B 100M Dec/2025
Myriad Genetics USD 209.8M 4.1M Dec/2025
Olympus JPY 261.05B 13.21B Dec/2025
OraSure Technologies USD 26.76M 322K Dec/2025
Quest Diagnostics USD 2.9B 90M Mar/2026
Repligen USD 197.91M 8.91M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
Stryker USD 7.2B 1.14B Dec/2025
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
Veracyte USD 140.6M 8.7M Dec/2025
Waters USD 932M 132M Dec/2025
Zimmer Biomet Holdings USD 2.09B 150M Mar/2026